Sangamo Therapeutics SGMO Sparks Speculation of a Turnaround as Investor Sentiment Shifts SANUWAVE Health SNWV Q1 2026 Results Miss Estimates EPS 018 vs 005 What Sidus Space SIDUs 956 Jump Means for Investors 20260515 TrumpXi Talks Very Successful but Trade Breakthroughs Remain Elusive Sangamo Therapeutics SGMO Q1 2026 Earnings Miss EPS 008 vs 001 Expected Kyverna Therapeutics KYTX Q1 2026 Earnings EPS 066 Beats Estimates COMPASS CMPS Q1 2026 Earnings Surprise EPS 030 Up Significant